E
0.990
-0.02 (-1.98%)
| Penutupan Terdahulu | 1.01 |
| Jumlah Dagangan | 19,571 |
| Harga / Buku (P/B) | 6.65 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -3.78 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.44% |
| Nisbah Semasa (MRQ) | 2.91 |
| Aliran Tunai Operasi (OCF TTM) | -4.06 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.23 M |
| Pulangan Atas Aset (ROA TTM) | -28.42% |
| Pulangan Atas Ekuiti (ROE TTM) | -86.28% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Exicure, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.4 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.35 |
|
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 63.15% |
| % Dimiliki oleh Institusi | 12.13% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prestige Wealth Management Group Llc | 30 Jun 2026 | 20 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |